Resumen
La transmisión de algunas enfermedades entre especies ha atraído la atención de los científicos desde el siglo XVIII.
El scrapie, la enfermedad de Creutzfeldt-Jakob y otras encefalopatías espongiformes permitieron identificar nuevos agentes infecciosos que no responden a los criterios tradicionales de las enfermedades infecciosas.
Los países y sus oficinas sanitarias deben mantener una vigilancia epidemiológica de su conducción respecto a las encefalopatías espongiformes.
Citas
Cuillé J, Chelle PL. La maladie dite tremblante du mouton est-elle inoculable? CR Acad Sci (París) 2003;936: 1552-1554.
Chandler RL. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1961; 1: 1378-1379.
Narang HK. A chronological study of experimental scrapie in mice. Virus Research 1988; 9: 293-306.
Gajdusek DC. Slow infections with unconventional viruses. The Harvey Lectures, Series 72. New York: Academic Press, 1976.
Creutzfeldt HG-Ueber eine eigenartige Erkrankung des Zentralnervensystem- Z ges Neurol Psychiat 1920,57:1-18.
Jakob A. Ueber eigenartige Erkrankungen des Centralnervensystem mit bemerkenswertem anatomischem Befunde (Spastische Pseudosklerose- Encephalomyelopathie mit disseminierten Degeneration sherden) Z Neurol Psychiat 1921; 64: 147-228.
Sigurdsson B. Rida, a chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. Br Vet J. 1954; 110: 341-354.
Gajdusek DC., Zigas V. Degenerative disease of the central nervous system in New Guinea. The endemia ocurrence of “Kuru” in the native population. N Engl J Med 1957; 257: 974-978.
Zigas V, Gajdusek DC. Kuru-clinical study of a new syndrome resembling paralysis agitans in natives of the eastern highlands of Australian New Guinea. Med J Aust 1957; 2:745.
Hadlow W. Scrapie and Kuru. Lancet 1 1959; 1097: 289-290.
Klatzo I, Gajdusek DC, Zigas V. Pathology of Kuru. Lab Invest 1959; 8: 799-847.
Gajdusek DC, Gibbs CJ Jr, Alpers M. Slow, Latent and Temperate virus infections- NINDB Monograph No.2 Washington DC. 1965.
Gibbs CJ, Gajdusek DC, Asher, DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanze. Science 1968; 161: 388-389.
Kirschbaum WR. Creutzfeldt-Jakob Disease. New York: American Elsevier, 1968.
Gajdusek DC, Gibbs CJ Jr. Transmission of two severe (subacute) spongiform encephalopathy of man, kuru and CJD to new world monkey. Nature 1971; 230: 180-191.
Duffy Ph, Wolf J., Collins, G, et al. Possible person to person transmission of Creutzfeldt-Jakob disease. New England J Med 1974; 291: 692.
Alpers MP, Gajdusek DC. Ono SG. Bibliography of Kuru - NIH - 1975.
Bernoulli C. Siegfried J, et. al. Danger of accidental person to person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 26: 478.
Gibbs CJ, Masters, Cl, Gajdusek DC. Bibliography of Creutzfeldt-Jakob disease. NIH Publ. No. 79 Washington. 1979.
Kuru. Early letters and Field - Notes from the collection of D Carleton Gajdusek. Edited by Judith Farquhar, D Carleton Gajdusek. Raven Press. 1981.
Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55: 1075-1081.
Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-144.
Beauvais P, Billette de Villemeur T. Maladie de Creutzfeldt-Jakob et autres Maladies a Prion. 1996. Medicine Sciences-Flammarion-Paris.
Dearmond SJ, Kretzschmar HA, Prusiner SB. Prion diseases. en Greenfield´s Neuropathology. David I Graham, Peter L. 7th Ed 2002; 2: 273-323.
Prusiner SB. Prion Biology and Diseases. American Academy of Neurology 2000 -Annual Education Program.
Budeck H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathology 1995; 5: 459-66.
Chiesa R, Harris DA. Prion Diseases: What is the neurotoxic molecula? Neurobiology of Disease 2001; 8: 743-763.
Sánchez E, Toro G, Uribe CS. Enfermedades causadas por priones. En: Uribe CA, Arana A, Lorenzana P- (eds). Fundamentos de Medicina - Neurología 6ª. Edición - Medellín: CIB 2002: 291-298.
Wells GA, Scott AC, Johnson CT. A novel progressive spongiform encephalopathy in cattle. Vet Res. 1987; 121: 419-420.
WHO Working group international reference materials for diagnosis and study of transmissible spongiform encephalopathies (TSEs). http www.who.int/technology/ biological.html
Bolis Cl, Gibbs CJ Jr. Proceedings of International Roundtable on Bovine Spongiform Encephalopathy. Summary Report and Recommendations. J Am Veterinary Med Assoc 1990; 196: 1673-1690.
Collee JG. Foodborne Illness. Bovine spongiform encephalopathy Lancet 1990; 336:1300-1303.
Crawford MA, Budowski P, Drury P, et al. The nutricional contribution to Bovine Spongiform Encephalopathy. Nutr and Health 1991;7: 61-68.
Epstein LG, Brown P. Bovine spongiform encephalopathy and new variant of Creutzfeldt-Jakob disease. Neurology 1997; 48: 569-571.
Brown P. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. BMJ 2001; 322: 841-844.
Encefalopatía Espongiforme Bobina (EEB. Toma y envío de muestras para el diagnóstico histopatológico - Ministerio de Agricultura y Desarrollo Rural e ICA, 2002.
Guía para la evaluación de la situación de la Encefalopatía Espongiforme Bovina (EEB) en Colombia. Ministerio de Agricultura y Desarrollo Rural e ICA - 2002.
Liberski PP, Yanagihara R, Wells GAH, Gibbs CJ, Gajdusek DC. Comparative ultrastructural neuropathology of naturally occuring Bovine Spongiform Encephalopathy and experimentally induced scrapie and Creutzfeldt-Jakob disease. J Comp Path 1992; 106: 361-381.
Liberski PP, Yanagihara R, Wells, GAH Gibbs, CJ, Gajdusek DC. Ultrastructural pathology of axons and myelin in experimental scrapie in hamsters and Bovine Spongiform Encephalopathy in cattle and a comparison with the Panencephalopathic type of Creutzfeldt-Jakob disease. J Comp Path 1992; 106: 383-398.
Report of a WHO consultation on clinical and neuropathological characteristics of the new variant of CJD and other human and animal transmissible spongiform encephalopathies. With the participation of the Office International des Epizooties (OIE) Geneva, Switzerland 14 to 16 May 1996. p. 1-19.
McLean CA, Ironside JW, Alpers MP, Brown PW, Cervenakova L, Anderson RMcD, Masters CL. Comparative neuropathology of kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype host. Brain Pathology 1998; 8:429-437.
Llewelyn CA. Possible transmissión of variant Creutzfeldt-Jakob disease by blood transfusión. Lancet 2003, 363:412-417.
Llewelyn CA. Hewitt PE, Knight RSG, et. al Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet; 363: 417-421.
Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt - Jakob disease in the UK. Lancet 1996; 347: 921-25.
Andrews NJ, Farrington CP, Cousens SN, Smith PG, Ward H, Knight RSG, Ironside JW, Will RG. Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet 2000 356: 481-482.
Toro G, Díaz A, Saad C. Ayer hoy ¿y mañana? de la Teoría Prion. Acta Neurol Colomb. 2002; 18: 187-203.
Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354:317-323.
Spencer MD, Knight RSG, Will RG. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 2002; 324: 1479-1482.
Ward HJT. Surveillance of variant Creutzfeldt-Jakob disease in the UK Eurosurveillance 2000; 5: 90-94.
Cousens SN, Linsell L, Smith PG, et al. Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 1999 353:18-21.
Prusiner SB, Hsiao KK. Human prion diseases. Ann Neurol 1994; 35: 385-395.
OMS - The revision of the surveillance case definition for variant Creutzfeldt-Jakob disease (vCJD) Edinburgh, United Kingdom 17 may 2001.
Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000; 47: 575-582.
Will RG, Stewart G, Zeidler M, et al. Psychiatric features of new variant Creutzfeldt-Jakob disease. Psychiatric Bulletin 1999; 23: 264-267.
Macleod MA, Knight R. Stewart G, Zeidler M., Will R. Sensory features of variant Creutzfeldt-Jakob disease. JNNP 2000 69: 413-414.
Ironside J.W. Pathology of variant Creutzfeldt- Jakob disease. Arch Virol Suppl 2000; 16: 143-151.
Lemstra AW, van Meegen MT, Vrciling JP, et al. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease. A prospective study in 112 patients. Neurology 2000; 55: 514-516.
Green AJE, Thompson EJ, Stewart G, et al. The use of CSF 14-3-3 and other brain specific proteins in the diagnosis of variant CJD. J Neurol Neurosurg Psychia 2001 70: 744-748.
Kawashima T, Furukawa H, Doh-ura K. Iwaki
T. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997 350: 68-69.
Hill AF, Butterworth R J, Joiner S et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353:183-189.
Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001 358 : 208-209.
Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that new variant CJD is caused by the BSE agent. Nature 1997. 6650: 498-501.
Hill AF, Desbruslais M, Joiner S, et al The same prion strain causes vCJD and BSE. Nature 1997 389 (6650): 448-450.
Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt- Jakob disease. Lancet 2000, 355: 1412-1418.
Ministerio de la Protección Social - Instituto Nacional de Salud -Guía para la Prevención, Vigilancia y Control de la variante de la Enfermedad de Creutzfeldt- Jakob (vCJ) - Integrado a SIVIGILA en abril de 2005 - Resumen en Acta de la reunión del COVE de enero 24 de 2005.
Gajdusek DC, Gibbs CJ Jr, Asher MD, et al. Precautions in medical care of and in handling materials from patients with transmissible virus dementia, Creutzfeldt-Jakob disease. New England J Med 1977; 297: 1253-1258.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.